67 L. Jacob, M. Zasloff, “Potential Therapeutic Applications of Magainins and Other Antimicrobial Agents of Animal Origin”, Ciba Foundation Symposia 186 (1994X197-223; Y. Ge et al., “In Vitro Susceptibility to Pexiganan of Bacteria Isolated from Infected Diabetic Foot Ulcers”, Diagnostic Microbiology and Infectious Disease 35 (1999), 45–53.
67
Ciba Foundation Symposia
Diagnostic Microbiology and Infectious Disease
68 Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Anti-infective Drugs Advisory Committee, 66th meeting, March 4, 1999 (стенограмма).
68
69 Rexford Ahima et al., “Appetite Suppression and Weight Reduction by a Centrally Active Aminosterol”, Diabetes 51 (2002), 2099–2104.
69
Diabetes
70 Graham Bell, Pierre-Henri Gouyon, “Arming the Enemy: The Evolution of Resistance to Self-Proteins”, Microbiology 149 (2003), 1367–1375.
70
Microbiology
71 Jack Lucentini, “Antibiotic Arms Race Heats Up”, Scientist, September 8, 2003, 29.
71
Scientist,
72 Gabriel Perron, Michael Zasloff, Graham Bell, “Experimental Evolution of Resistance to an Antimicrobial Peptide”, Proceedings of the Royal Society B 273 (2006), 251–256.
72
Proceedings of the Royal Society B
73 Charlotte Schubert, “Microbes Overcome Natural Antibiotic”, news@nature.com, November 2, 2005, www.nature.com/news/20 05 / 051031 / full / news051031-5.html.
73